The Norwegian Radium Hospital, The Research Building
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".
For the month of June 2017, this honour went to CCB's Principal Investigator professor Håvard Danielsen, head of the Institute for Cancer Genetics and Informatics at Oslo University Hospital.
Microsatellite instability (MSI) defines a small subgroup of approximately 15% of colorectal cancers (CRC) which currently receives much attention due to its overall good response to immune-checkpoint inhibition. In the latest issue of Genome Medicine, scientist Anita Sveen and colleagues publish the largest multilevel genetic analysis of this tumor type reported to date, describing substantial inter- and intra-tumor heterogeneity. The clinical importance of these results, in particular with respect to the optimized use of immunotherapeutics for treatment of human cancers, was emphasized in a Research Highlight in the same issue of the journal.
The New York based news organization GenomeWeb recently presented an in-depth article about the Oslo University Hospital's efforts of developing a urine-based test for monitoring of bladder cancer patients. Professor Guro Lind presented the project at the Oslo Life Science Conference 2017 previously this year. The project drew the attention of Bjarne Røsjø in Titan and was later picked up by GenomeWeb.
On the 16th of June, six research prizes were awarded to scientists from Oslo University Hospital. CCBs June Myklebust was among the prize winners. June Myklebust is Co-PI of Erlend Smeland's group at the Department of Immunology, Institute for Cancer Research, Oslo University Hospital.
On Friday the 5th of May CCB Principal Investigator Kirsten Sandvig was awarded the Oslo University Hospital Excellent Researcher Award of 300.000 NOK.